NGENF (NervGen Pharma) Total Stockholders Equity : $1.81 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Total Stockholders Equity?

NervGen Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $1.81 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. NervGen Pharma's Book Value per Share for the quarter that ended in Dec. 2024 was $0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. NervGen Pharma's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.04.

NervGen Pharma Total Stockholders Equity Historical Data

The historical data trend for NervGen Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Total Stockholders Equity Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

4.62

13.14

9.91

-1.50

1.81

NervGen Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															-1.50	13.91	9.11	6.78	1.81

NervGen Pharma (OTCPK:NGENF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

NervGen Pharma's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1.809	-	0)	/	70.308
	=	0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

NervGen Pharma's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.068	+	0.006)	/	1.809
	=	0.04

NervGen Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (OTCPK:NGENF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

9UA:Germany NGEN:Canada

Address

112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4

Website

https://www.nervgen.com

NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.

NervGen Pharma Headlines

From GuruFocus

NervGen Pharma To Webcast At VirtualInvestorConferences.com July 11th

By PRNewswire PRNewswire • 07-09-2019